ResearcherHarvard UniversityActive in the last 2 years
Taisuke Baba
Matched on ORCID iD 0000-0002-0189-7396; OpenAlex author ID A5024600322, A5065757889. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 39
2022: 3 papers · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 6
- FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation. Co-author DOI 10.1111/cas.70212↗
- Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. Co-author DOI 10.1158/2767-9764.crc-24-0392↗
- Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.16245↗
- A Lesson in Transcriptional Plasticity: Classical Identity Is Silenced, but Not Lost, in Pancreatic Ductal Adenocarcinoma Cell Lines. Co-author DOI 10.1053/j.gastro.2022.07.005↗
- Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. Co-author DOI 10.1097/sla.0000000000005433↗
- Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cance… Co-author DOI 10.3390/cancers14040868↗
Closest collaborators
The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keith D. Lillemoe · 3 shared papers, 2022–2025 · strength 0.49
- Paper Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. DOI 10.1158/2767-9764.crc-24-0392↗
- Paper A Lesson in Transcriptional Plasticity: Classical Identity Is Silenced, but Not Lost, in Pancreatic Ductal Adenocarcino… DOI 10.1053/j.gastro.2022.07.005↗
- Paper Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. DOI 10.1097/sla.0000000000005433↗
- Louisa Bolm · 3 shared papers, 2022–2025 · strength 0.44
- Paper Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. DOI 10.1158/2767-9764.crc-24-0392↗
- Paper Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. DOI 10.1097/sla.0000000000005433↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Kim C. Honselmann · 3 shared papers, 2022–2025 · strength 0.44
- Paper Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. DOI 10.1158/2767-9764.crc-24-0392↗
- Paper Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. DOI 10.1097/sla.0000000000005433↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Natalie Petruch · 3 shared papers, 2022–2025 · strength 0.44
- Paper Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. DOI 10.1158/2767-9764.crc-24-0392↗
- Paper Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. DOI 10.1097/sla.0000000000005433↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Jon Michael Harrison · 3 shared papers, 2022–2025 · strength 0.44
- Paper Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. DOI 10.1158/2767-9764.crc-24-0392↗
- Paper Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. DOI 10.1097/sla.0000000000005433↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Toshio Kokuryo · 2 shared papers, 2023–2025 · strength 0.40
- Shunsuke Onoe · 2 shared papers, 2023–2025 · strength 0.40
- Junpei Yamaguchi · 2 shared papers, 2023–2025 · strength 0.40
- Masaki Sunagawa · 2 shared papers, 2023–2025 · strength 0.40
- Tomoki Ebata · 2 shared papers, 2023–2025 · strength 0.40
- Andrew Louis Warshaw · 2 shared papers, 2022–2025 · strength 0.37
- Paper Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. DOI 10.1158/2767-9764.crc-24-0392↗
- Paper A Lesson in Transcriptional Plasticity: Classical Identity Is Silenced, but Not Lost, in Pancreatic Ductal Adenocarcino… DOI 10.1053/j.gastro.2022.07.005↗
- Andrew Scott Liss · 2 shared papers, 2022–2025 · strength 0.37
- Paper Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5. DOI 10.1158/2767-9764.crc-24-0392↗
- Paper A Lesson in Transcriptional Plasticity: Classical Identity Is Silenced, but Not Lost, in Pancreatic Ductal Adenocarcino… DOI 10.1053/j.gastro.2022.07.005↗
- Carlos F. Fernandez-del Castillo · 2 shared papers, 2022–2025 · strength 0.33
- Carlos Fernández-del Castillo · 2 shared papers, 2022 · strength 0.28
- Paper A Lesson in Transcriptional Plasticity: Classical Identity Is Silenced, but Not Lost, in Pancreatic Ductal Adenocarcino… DOI 10.1053/j.gastro.2022.07.005↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Shoji Kawakatsu · 1 shared paper, 2025 · strength 0.25
- Motonobu Nishimura · 1 shared paper, 2025 · strength 0.25
- Tobias Keck · 2 shared papers, 2022 · strength 0.23
- Ulrich Friedrich Wellner · 2 shared papers, 2022 · strength 0.23
- David Tsai Ting · 1 shared paper, 2025 · strength 0.21
- Thomas P. Hank · 1 shared paper, 2025 · strength 0.21
- Marta Sandini · 1 shared paper, 2025 · strength 0.21
- Mari A. Mino-Kenudson · 1 shared paper, 2025 · strength 0.21
- François Bertucci · 1 shared paper, 2022 · strength 0.16
- David Jérémie Birnbaum · 1 shared paper, 2022 · strength 0.16
- Mikiko Kano Takebayashi · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.